Clinical benefits and safety of FMS-like tyrosine kinase 3 inhibitors in various treatment stages of acute myeloid leukemia: a systematic review, meta-analysis, and network meta-analysis - Xu, Qingyu; He, Shujiao; Yu, Li (Frontiers in oncology, 2021)
Gesehen am 02.06.2023